Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: Comparison with tumour regression grade at histology

European Radiology

Volumn 23, Issue 8, 2013, Pages 2165-2174

  De Cobelli, Francesco ^a   Giganti, Francesco ^a   Orsenigo, Elena ^a   Cellina, Michaela ^b   Esposito, Antonio ^a   Agostini, Giulia ^a   Albarello, Luca ^c   Mazza, Elena ^c   Ambrosi, Alessandro ^a   Socci, Carlo ^a   Staudacher, Carlo ^a   Del Maschio, Alessandro ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Apparent diffusion coefficient; Diagnosis; Diffusion magnetic resonance imaging; Gastroesophageal cancer; Response to neoadjuvant therapy

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; STOMACH ADENOCARCINOMA; TISSUE SECTION; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR REGRESSION;

ADULT; AGED; BIOPSY; DIFFUSION MAGNETIC RESONANCE IMAGING; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM GRADING; OBSERVER VARIATION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84880328736     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2807-0     Document Type: Article

References (37)

1. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Eng J Med 355:11-20
2. Sendler A (2010) Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res 182:167-177
3. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114:210-217
4. Shimada H, Okazumi S, Koyama M, Japanese MK (2011) Gastric cancer association task force for research promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric and esophageal cancer. Cancer 14:13-21
5. Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ (2006) Role of positron emission tomography in the (re-)staging of oesophageal cancer. Scand J Gastroenterol Suppl 2006:116-122
6. Brücher BL, Weber W, Bauer M et al (2001) Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 233:300-309
7. Smithers BM, Couper GC, Thomas JM et al (2008) Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. Dis Esophagus 21:151-158
8. Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317
9. Ott K, Fink U, Becker K et al (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21:4604-4610
10. Padhani AR (2002) Functional MRI for anticancer therapy assessment. Eur J Cancer 38:2116-2127
11. Koh DM, Padhani AR (2006) Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol 79:633-635
12. Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, Husband JE (2007) Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 188:1001-1008
13. Figueiras RG, Goh V, Padhani AR, Naveira AB, Caamaño AG, Martin CV (2010) The role of functional imaging in colorectal cancer. AJR Am J Roentgenol 195:54-66
14. Harry VN (2010) Novel imaging techniques as response biomarkers in cervical cancer. Gynecol Oncol 116:253-261
15. Hein PA, Kremser C, Judmaier W et al (2003) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214-222
16. Kim SH, Lee JY, Lee JM, Han JK, Choi BI (2011) Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 21:987-995
17. Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680-2686
18. Hermann RM, Horstmann O, Haller F et al (2006) Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use? Dis Esophagus 19:329-334
19. Vecchio FM, Valentini V, Minsky BD et al (2005) The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752-760
20. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457-1459
21. Barbaro B, Fiorucci C, Tebala C et al (2009) Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 250:730-739
22. Lambrecht M, Vandecaveye V, De Keyzer F et al (2012) Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer. Int J Radiat Oncol Biol Phys 82:863-870
23. Aoyagi T, Shuto K, Okazumi S, Shimada H, Kazama T, Matsubara H (2011) Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surgery 28:252-257
24. Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, Zhang XY (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254:170-178
25. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360:307-308
26. Cui Y, Zhang XP, Sun YS, Tang L, Shen L (2008) Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 248:894-900
27. Tang L, Zhang XP, Sun YS, Shen L, Li J, Qi LP, Cui Y (2011) Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients. Radiology 258:729-738
28. Park SH, Moon WK, Cho N et al (2010) Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 257:56-63
29. Dudeck O, Zeile M, Pink D et al (2008) Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 27:1109-1113
30. Sun YS, Cui Y, Tang L et al (2011) Early evaluation of cancer response by a new functional biomarker: apparent diffusion coefficient. AJR Am J Roentgenol 197:23-29
31. Yankeelov TE, Lepage M, Chakravarthy A et al (2007) Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25:1-13
32. Forastiere AA, Ang K, Brizel D et al (2005) National comprehensive cancer network. Head and neck cancers. J Natl Compr Cancer Netw 3:316-391
33. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
34. Lee KC, Moffat BA, Schott AF et al (2007) Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 13:443-450
35. Harry VN, Semple SI, Gilbert FJ, Parkin DE (2008) Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111:213-220
36. Lambregts DM, Beets GL, Maas M, Curvo-Semedo L, Kessels AG, Thywissen T, Beets-Tan RG (2012) Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol 21:2567-2574
37. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York